UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 394

Sortiert nach

Quality of life in thalassemia: A comparison of SF‐36 results from the thalassemia longitudinal cohort to reported literature and the US norms

American journal of hematology, 2011-01, Vol.86 (1), p.92-95

2011

Volltextzugriff (PDF)

Prevalence of fractures among the Thalassemia syndromes in North America

Bone (New York, N.Y.), 2006-04, Vol.38 (4), p.571-575

2006

Volltextzugriff (PDF)

Effect of Transfusional Iron Overload on Immune Response

The Journal of infectious diseases, 2000-09, Vol.182 (Supplement-1), p.S115-S121

2000

Volltextzugriff (PDF)

Chelation therapy in β-thalassemia: An optimistic update

Seminars in hematology, 2001-10, Vol.38 (4), p.360-366

2001

Volltextzugriff (PDF)

Long-Term Generation of Colony-Forming Cells in Liquid Culture of CD34+ Cord Blood Cells in the Presence of Recombinant Human Stem Cell Factor

Blood, 1992-05, Vol.79 (10), p.2620-2627

1992

Volltextzugriff (PDF)

Chelation therapy in beta-thalassemia: the benefits and limitations of desferrioxamine

Seminars in hematology, 1995-10, Vol.32 (4), p.304

1995

Volltextzugriff (PDF)

Deferoxamine-induced bone dysplasia in patients with thalassemia major

American journal of roentgenology (1976), 1991-03, Vol.156 (3), p.561

1991

Volltextzugriff (PDF)

Prolonged survival in patients with beta-thalassemia major treated with deferoxamine

The Journal of pediatrics, 1991-04, Vol.118 (4), p.540-545

1991

Volltextzugriff (PDF)

Pulmonary function abnormalities in thalassemia major and the role of iron overload

American journal of respiratory and critical care medicine, 1994-06, Vol.149 (6), p.1570

1994

Volltextzugriff (PDF)

Effects of recombinant human stem cell factor (SCF) on the growth of human progenitor cells in vitro

Journal of cellular physiology, 1991-09, Vol.148 (3), p.503-509

1991

Volltextzugriff (PDF)

Toward optimizing the use of deferasirox: potential benefits of combined use with deferoxamine

Haematologica (Roma), 2013-01, Vol.98 (1), p.129-135

2013

Volltextzugriff (PDF)

Sensorimotor neurotoxicity associated with high-dose deferoxamine treatment

Journal of pediatric hematology/oncology, 1997-03, Vol.19 (2), p.139-141

1997

Volltextzugriff (PDF)

Results from a phase I clinical trial of HBED

Advances in experimental medicine and biology, 1994, Vol.356, p.351

1994

Volltextzugriff (PDF)

β -thalassemia in Chinese: Use of in vivo RNA Analysis and Oligonucleotide Hybridization in Systematic Characterization of Molecular Defects

Proceedings of the National Academy of Sciences - PNAS, 1984-05, Vol.81 (9), p.2821-2825

1984

Volltextzugriff (PDF)

Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial

The Lancet (British edition), 2003-05, Vol.361 (9369), p.1597-1602

2003

Volltextzugriff (PDF)

β-Thalassemia Due to Two Novel Nucleotide Substitutions in Consensus Acceptor Splice Sequences of the β-Globin Gene

Blood, 1989-03, Vol.73 (4), p.914-918

1989

Volltextzugriff (PDF)

Decreased natural killer activity in thalassemia major: a possible consequence of iron overload

The Journal of immunology (1950), 1986-03, Vol.136 (5), p.1635

1986

Volltextzugriff (PDF)

Survival and Morbidity in Transfusion-dependent Thalassemic Patients on Subcutaneous Desferrioxamine Chelation: Nearly Two Decades of Experience

Annals of the New York Academy of Sciences, 1998-06, Vol.850 (1), p.469-470

1998

Volltextzugriff (PDF)

The changing profile of homozygous beta-thalassemia: demography, ethnicity, and age distribution of current North American patients and changes in two decades

Pediatrics (Evanston), 1996-03, Vol.97 (3), p.352

1996

Volltextzugriff (PDF)

Update on thalassemia

Pediatrics in review, 1992-02, Vol.13 (2), p.55

1992

Volltextzugriff (PDF)

Iron chelation with oral deferiprone in patients with thalassemia

The New England journal of medicine, 1998-12, Vol.339 (23), p.1712

1998

Volltextzugriff (PDF)

Low Bone Mineral Density in Adolescents with β-Thalassemia

Annals of the New York Academy of Sciences, 2005-11, Vol.1054 (1), p.462-466

2005

Volltextzugriff (PDF)

Modulation of the defective natural killer activity seen in thalassaemia major with desferrioxamine and α-interferon

Clinical and experimental immunology, 1987-11, Vol.70 (2), p.345-353

1987

Volltextzugriff (PDF)

Inflammation and oxidant-stress in {beta}-thalassemia patients treated with iron chelators deferasirox (ICL670) or deferoxamine: an ancillary study of the Novartis CICL670A0107 trial

Haematologica (Roma), 2008-06, Vol.93 (6), p.817-825

2008

Volltextzugriff (PDF)

Safety and efficacy of pegylated interferon {alpha}-2a and ribavirin for the treatment of hepatitis C in patients with thalassemia

Haematologica (Roma), 2008-08, Vol.93 (8), p.1247-1251

2008

Volltextzugriff (PDF)

1 – 25 von 394

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(358)
Mit Volltextzugriff
(335)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(246)
Life Sciences & Biomedicine
(168)
Humans
(149)
Biological And Medical Sciences
(83)
Female
(81)
Male
(73)
Physical Sciences
(65)
Medical Sciences
(62)
Physics
(60)
Adult
(50)
Animals
(42)
Middle Aged
(35)
Adolescent
(33)
Child
(29)
Fundamental And Applied Biological Sciences. Psychology
(27)
Hematologic And Hematopoietic Diseases
(25)
Hematology
(25)
Physics, Nuclear
(25)
Anemias. Hemoglobinopathies
(23)
Diseases Of Red Blood Cells
(23)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Quality of life in thalassemia: A comparison of SF‐36 results from the thalassemia longitudinal cohort to reported literature and the US norms

Prevalence of fractures among the Thalassemia syndromes in North America

Effect of Transfusional Iron Overload on Immune Response

Chelation therapy in β-thalassemia: An optimistic update

Long-Term Generation of Colony-Forming Cells in Liquid Culture of CD34+ Cord Blood Cells in the Presence of Recombinant Human Stem Cell Factor

Chelation therapy in beta-thalassemia: the benefits and limitations of desferrioxamine

Deferoxamine-induced bone dysplasia in patients with thalassemia major

Prolonged survival in patients with beta-thalassemia major treated with deferoxamine

Pulmonary function abnormalities in thalassemia major and the role of iron overload

Effects of recombinant human stem cell factor (SCF) on the growth of human progenitor cells in vitro

Toward optimizing the use of deferasirox: potential benefits of combined use with deferoxamine

Sensorimotor neurotoxicity associated with high-dose deferoxamine treatment

Results from a phase I clinical trial of HBED

β -thalassemia in Chinese: Use of in vivo RNA Analysis and Oligonucleotide Hybridization in Systematic Characterization of Molecular Defects

Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial

β-Thalassemia Due to Two Novel Nucleotide Substitutions in Consensus Acceptor Splice Sequences of the β-Globin Gene

Decreased natural killer activity in thalassemia major: a possible consequence of iron overload

Survival and Morbidity in Transfusion-dependent Thalassemic Patients on Subcutaneous Desferrioxamine Chelation: Nearly Two Decades of Experience

The changing profile of homozygous beta-thalassemia: demography, ethnicity, and age distribution of current North American patients and changes in two decades

Update on thalassemia

Iron chelation with oral deferiprone in patients with thalassemia

Low Bone Mineral Density in Adolescents with β-Thalassemia

Modulation of the defective natural killer activity seen in thalassaemia major with desferrioxamine and α-interferon

Inflammation and oxidant-stress in {beta}-thalassemia patients treated with iron chelators deferasirox (ICL670) or deferoxamine: an ancillary study of the Novartis CICL670A0107 trial

Safety and efficacy of pegylated interferon {alpha}-2a and ribavirin for the treatment of hepatitis C in patients with thalassemia

Suchergebnisse filtern